Search

Your search keyword '"Cabrera, Alvin R."' showing total 24 results
Start Over Author "Cabrera, Alvin R."
24 results on '"Cabrera, Alvin R."'

1. List of contributors

Author

Aaron, Daniel, primary, Abrams, Ross A., additional, Agarwal, Mohit S., additional, Agbafe, Victor, additional, Ajaikumar, B.S., additional, Anderson, Eric M., additional, Bakal, Jeffrey A., additional, Banson, Kara, additional, Beltrán Ponce, Sara, additional, Benitez, C.M., additional, Bhavnani, Suresh K., additional, Bitterman, Danielle S., additional, Blumenfeld, Philip, additional, Bowar, Breann E., additional, Bradfield, Lisa, additional, Braunstein, Lior Z., additional, Buss, Elizabeth J., additional, Byrne, James D., additional, Cabrera, Alvin R., additional, Campos, Juan Jose, additional, Casak, Sandra J., additional, Casey, Dana, additional, Catalano, Paul J., additional, Chan, Michael D., additional, Chaurasia, Aditi, additional, Chen, Hanbo, additional, Chen, Yi-Fan, additional, Cho, Hae Lin, additional, Chowdhry, Varun Kumar, additional, Chua, Michelle, additional, Chung, Hans T., additional, Corbin, Jereme, additional, Cramer, Christina, additional, Crowley, Aidan, additional, D'Amico, Anthony, additional, Dahir, Anisa, additional, Damian Riina, Matthew, additional, Dee, Edward Christopher, additional, Derton, Abigail, additional, Dicker, Adam, additional, Dickstein, Daniel R., additional, Domogauer, Jason, additional, Donovan, Elysia K., additional, Dudley, Sara A., additional, Dushyanthen, Sathana, additional, Eala, Michelle, additional, El Badawy, Samy A., additional, Elkins, Ivy, additional, Facer, Benjin D., additional, Feldman, Jill, additional, Fields, Emma C., additional, Franco, Idalid, additional, Gandhi, Ajeet Kumar, additional, Gandhy, Shruti U., additional, Garda, Allison E., additional, George Paul, Arun, additional, Ghosh, Mithua, additional, Giuliani, Meredith, additional, Golden, Daniel W., additional, Gota, Vikram, additional, Grace, Holly, additional, Guo, Jimmy A., additional, Gupta, Deepak, additional, Gupta, Gaorav, additional, Haley, Kathryn E., additional, Han, Nyun Calvin, additional, Hanania, Hannah L., additional, Hanania, Alexander N., additional, Hartman, Holly, additional, Hatch, Sandra, additional, Hoffman, Hannah I., additional, Hsieh, Kristin, additional, Huang, Eng-Yen, additional, Huber, Kathryn E., additional, Hwang, William L., additional, Ifrah, Sheindel, additional, Jagsi, Reshma, additional, Jones, Brianna M., additional, Jones, Gavin Paul, additional, Khan, Qateeb A., additional, Kakkar, Sajal, additional, Kataria, Tejinder, additional, Katz, Leah M., additional, Kennedy, William R., additional, Kim, Daniel W., additional, Kim, In Ah, additional, Kishan, Amar U., additional, Knoll, Miriam A., additional, Kok, David L., additional, Kopecky, Andrew, additional, Kumar, Sharath, additional, Lam, Miranda B., additional, Lamkin, Erica N., additional, Le, Quynh-Thu, additional, LeCompte, Michael, additional, Lee, David J., additional, Lee, Grace, additional, Lee, Jennifer J., additional, Lee, Anna, additional, Lehrer, Eric J., additional, Li, Puyao C., additional, Liu, Chia, additional, Loeffler, Jay, additional, Lohith, G., additional, Ma, Ting Martin, additional, Machtay, Mitchell, additional, Mahajan, Shaifali, additional, Mailhot Vega, Raymond B., additional, Maity, Amit, additional, Mallick, Supriya, additional, Marchan, Ed M., additional, Martin, Neil, additional, Mattessich, Sarah, additional, Mayhew, David L., additional, Mehra, Prateek, additional, Michaeli, Tal Falick, additional, Mishra, Vachaspati, additional, Mortensen, Eric M., additional, Mukherjee, Dibya, additional, Murthy, Vedang, additional, Nakfoor, Bruce, additional, Newman, Neil Bryan, additional, Nguyen, Paul L., additional, Niska, Joshua R., additional, Niska, Emily E., additional, Ozcan, Gonca, additional, Padilla, Oscar, additional, Patton, Caroline D., additional, Perlow, Haley K., additional, Perni, Subha, additional, Pfeffer, Raphael, additional, Pfister, Neil Thomas, additional, Poojari, Avinash, additional, Prasad, Rahul N., additional, Prim, Shih-Ni, additional, Pursley, Jennifer, additional, Raldow, Ann C., additional, Ramirez, Nicholas, additional, Rastogi, Madhup, additional, Ridge, Natalie A., additional, Ritter, Alex R., additional, Rosenberg, Jennifer, additional, Roy, Soumyajit, additional, Ruiz, Jimmy, additional, Sanai, Nader, additional, Saraf, Anurag, additional, Sarkar, Soumya, additional, Sekar, Krithikaa, additional, Shah, Chirag, additional, Shukla, Utkarsh C., additional, Phillip Silver, Benjamin, additional, Sim, Austin J., additional, Singh, Raj, additional, Singh, Meghana, additional, Smith, Benjamin D., additional, Spelic, David C., additional, Stambaugh, Cassandra, additional, Stambaugh, Nathaniel, additional, Sud, Shivani, additional, Sueyoshi, Mark, additional, Sullivan, Julie M., additional, Suneja, Gita, additional, Thomas, Justin J., additional, Timothy Hsiao, H., additional, Ufondu, Adannia N., additional, Urias, Eduardo, additional, Vashistha, Bhanu, additional, Vashistha, Rajesh, additional, Verma, Prabha, additional, Walker, Amanda J., additional, Wang, Sue-Jane, additional, Wang, Tony J.C., additional, Wang, Kaidi, additional, Warner, Jeremy L., additional, Wolfe, Adam R., additional, Wunnava, Susmitha, additional, Yacoub, Irini Ihab, additional, Yom, Sue S., additional, Zaghloul, Mohamed S., additional, and Zaky, Sandra S., additional

Published
2023
Full Text
View/download PDF

2. Clinical guideline development

Author

Zaky, Sandra S., primary, Bradfield, Lisa, additional, Patton, Caroline D., additional, Cabrera, Alvin R., additional, and Smith, Benjamin D., additional

Published
2023
Full Text
View/download PDF

3. Radiation Therapy for Brain Metastases: An ASTRO Clinical Practice Guideline

Author

Gondi, Vinai, Bauman, Glenn, Bradfield, Lisa, Burri, Stuart H., Cabrera, Alvin R., Cunningham, Danielle A., Eaton, Bree R., Hattangadi‐Gluth, Jona A., Kim, Michelle M., Kotecha, Rupesh, Kraemer, Lianne, Li, Jing, Nagpal, Seema, Rusthoven, Chad G., Suh, John H., Tomé, Wolfgang A., Wang, Tony J.C., Zimmer, Alexandra S., Ziu, Mateo, and Brown, Paul D.

Published
2022
Full Text
View/download PDF

17. Prostate Cancer: Is Inapparent Tumor at Endorectal MR and MR Spectroscopic Imaging a Favorable Prognostic Finding in Patients Who Select Active Surveillance?1

Author

Cabrera, Alvin R., Coakley, Fergus V., Westphalen, Antonio C., Lu, Ying, Zhao, Shoujun, Shinohara, Katsuto, Carroll, Peter R., and Kurhanewicz, John

Subjects
Adult, Aged, 80 and over, Male, Magnetic Resonance Spectroscopy, Biopsy, Needle, Prostatic Neoplasms, Middle Aged, Prognosis, Magnetic Resonance Imaging, Logistic Models, Predictive Value of Tests, Image Interpretation, Computer-Assisted, Humans, Original Research, Aged, Retrospective Studies
Abstract

To retrospectively determine whether inapparent tumor at endorectal magnetic resonance (MR) imaging and MR spectroscopic imaging is a favorable prognostic finding in prostate cancer patients who select active surveillance for management.Committee on Human Research approval was obtained and compliance with HIPAA regulations was observed, with waiver of requirement for written consent. Ninety-two men (mean age, 64 years; range, 43-85 years) were retrospectively identified who had biopsy-proved prostate cancer, who had undergone baseline endorectal MR imaging and MR spectroscopic imaging, and who had selected active surveillance for management. Their mean baseline serum prostate-specific antigen (PSA) level was 5.5 ng/mL, and the median Gleason score was 6. Two readers with 10 and 3 years of experience independently reviewed all MR images and determined whether tumor was apparent on the basis of evaluation of established morphologic and metabolic findings. Another investigator compiled data about baseline clinical stage, biopsy findings, and serum PSA measurements. Multiple logistic regression analysis was used to investigate the relationship between the clinical parameters and tumor apparency at MR imaging and the biochemical outcome.At baseline MR imaging, readers 1 and 2 considered 54 and 26 patients, respectively, to have inapparent tumor (fair interobserver agreement; kappa = 0.30). During a mean follow-up of 4.8 years, 52 patients had a stable PSA level and 40 had an increasing PSA level. In multivariate analysis, no significant association was found between the baseline clinical stage, Gleason score, serum PSA level, or the presence of apparent tumor at endorectal MR imaging and MR spectroscopic imaging for either reader and the biochemical outcome (P.05 for all).Endorectal MR imaging and MR spectroscopic imaging findings of tumor apparency or inapparency in prostate cancer patients who select active surveillance for management do not appear to be of prognostic value.

Published
2008

19. Concurrent Stereotactic Radiosurgery and Bevacizumab in Recurrent Malignant Gliomas: A Prospective Trial

Author

Cabrera, Alvin R., primary, Cuneo, Kyle C., additional, Desjardins, Annick, additional, Sampson, John H., additional, McSherry, Frances, additional, Herndon, James E., additional, Peters, Katherine B., additional, Allen, Karen, additional, Hoang, Jenny K., additional, Chang, Zheng, additional, Craciunescu, Oana, additional, Vredenburgh, James J., additional, Friedman, Henry S., additional, and Kirkpatrick, John P., additional

Published
2013
Full Text
View/download PDF

21. Measuring Tumor Cell Proliferation with 18F-FLT PET During Radiotherapy of Esophageal Squamous Cell Carcinoma: A Pilot Clinical Study

Author

Yue, Jinbo, primary, Chen, Lusheng, additional, Cabrera, Alvin R., additional, Sun, Xindong, additional, Zhao, Shuqiang, additional, Zheng, Fu, additional, Han, Anqin, additional, Zheng, Jinsong, additional, Teng, Xuezhong, additional, Ma, Li, additional, Ma, Yidong, additional, Han, Dali, additional, Zhao, Xianguang, additional, Mu, Dianbin, additional, Yu, Jinming, additional, and Li, Yuhui, additional

Published
2010
Full Text
View/download PDF

24. Histopathologic validation of 3'-deoxy-3'-18F-fluorothymidine PET for detecting tumor repopulation during fractionated radiotherapy of human FaDu squamous cell carcinoma in nude mice18F-FLT PET repopulation.

Author

Jin-Bo Yue, Jia Yang, Jing Liu, Lee, Jason, Cabrera, Alvin R., Xin-Dong Sun, Guang-Hui Bai, Yu-Hui Li, and Jin-Ming Yu

Subjects
*TUMOR diagnosis, *SQUAMOUS cell carcinoma, *CANCER radiotherapy, *POSITRON emission tomography, *LABORATORY mice, CANCER histopathology
Abstract

Background and purpose FaDu human squamous cell carcinoma (FaDu-hSCC) demonstrates accelerated tumor repopulation during fractionated irradiation with pathological validation (Ki-67 and BrdUrd makers) in a xenograft model system. However, these and other functional assays must be performed ex vivo and post hoc. We propose a novel, in vivo, real-time assay utilizing 18F-FLT PET. Material and methods Nude mice with FaDu-hSCC were irradiated with 12 or 18 fractions of 1.8 Gy ([Dm] = 3.0 Gy), either daily or every second day. 18F-FLT micro-PET scans were performed at different time points, FLT parameters (SUVmax, SUVmean, and T/NT) were measured. Tumor sections were stained for Ki-67 and BrdUrd, a labeling index (LI) was calculated. Imaging-pathology correlation was determined by comparing FLT parameters and immunohistochemical results. Results Measured SUVmax, SUVmean and T/NT decreased significantly after daily irradiation with 12 fractions in 12 days (P < 0.05) and 18 fractions in 18 days (P < 0.05). In contrast, these parameters increased in mice treated with 12 fractions in 24 days (P > 0.05) and 18 fractions in 36 days (P > 0.05), suggesting accelerated repopulation. Similarly, Ki-67 and BrdUrd LIs demonstrated significant decreases with daily irradiation (P < 0.05), and increases with every-second-day irradiation (P > 0.05). 18F-FLT parameters correlated strongly with proliferation markers (r²: 0.679-0.879, P < 0.001). Conclusions 18F-FLT parameters were in good agreement with Ki-67 and BrdUrd Li. These results may support a potential role for 18F-FLT PET in real-time detection of tumor repopulation during fractionated radiotherapy. [ABSTRACT FROM AUTHOR]

Published
2014
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results